Moderna's chief medical officer on its blockb...

Up next

2021's challenges for journalism

Axios Re:Cap is revisiting some of this year’s biggest stories and what they say about where technology, business, politics and more are headed in 2022. Axios cofounder and CEO Jim VandeHei joins Axios Re:Cap senior producer Naomi Shavin to talk about what journalists got right a ... Show more

. 18min 20sec

The year psychedelics went mainstream

Axios Re:Cap is revisiting some of this year’s biggest stories and what they say about where technology, business, politics and more are headed in 2022. Alison Snyder, managing editor and author of Axios Science, joins Axios Re:Cap senior producer Naomi Shavin to discuss a major ... Show more

. 11min 21sec

Recommended Episodes

Ex-CDC director Tom Frieden on the next COVID-19 vaccines

Axios Re:Cap

Americans fortunate enough to receive vaccines right now, outside of clinical trials, are getting ones made by either Pfizer or Moderna. But newly released data from Novavax and Johnson & Johnson suggests that more vaccines could be on the way. Dan digs into the news and why it m ... Show more

. 15min 44sec

U.S. closer to first single-dose vaccine after Johnson & Johnson version clears major FDA hurdle; Dem divide on Biden OMB nominee, push for $15 minimum wage; Sheriff: Woods’ survival from crash “nothing short of a miracle”; First interview with Biden’s Veterans Affairs Secretary

The Lead with Jake Tapper

Promising signs in pandemic: vaccine progress, cases and hospitalizations down, deaths slow in new estimate; WH: 3-4 million doses of J&J vaccine to go out next week if FDA grants emergency use; Moderna testing vaccine boosters to combat South Africa variant; WH: J&J’s production ... Show more

. 44min 36sec

Moderna CEO Talks New Drugs

Bloomberg Talks

Moderna CEO Stephane Bancel talks about the Moderna vaccine, drug prices, and future of the company with Bloomberg's Paul Sweeny and Matt Miller. See omnystudio.com/listener for privacy information.

. 9min 22sec